We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Magnetic Robot That Moves Through Arteries Could Revolutionize Stroke Treatment

By HospiMedica International staff writers
Posted on 16 Feb 2024

Ischemic stroke occurs when the blood supply to the brain is interrupted due to a blockage in blood vessels. More...

Now, a cutting-edge technology promises to revolutionize stroke treatment. Scientists have created a magnetically operated robot for the treatment of ischemic stroke that is small enough to navigate the complex network of tiny blood vessels in the human brain. The robot restores blood flow by drilling through the blockage material in the brain, helping improve the motor functions and overall recovery of stroke patients.

This robot developed at ETH Zurich (Zurich, Switzerland) is propelled by an external magnet, and features a soft tip to avoid damaging blood vessels. Its soft tip reduces the risk of vascular damage, prioritizing patient safety. The robot's primary role is to penetrate the material obstructing the brain's blood flow, thereby restoring normal circulation. A standout feature is its precision and ability to adapt to the complex vascular structure of the human brain. Operated by an external magnet, the robot can rotate and move forward in a controlled way, marking a significant advancement in stroke therapy that could greatly enhance patient outcomes.

The robot has undergone extensive testing for effectiveness and safety, including trials in silicone models that simulate human blood vessels, as well as experiments using a human placenta and a live pig to assess performance in living tissues. These tests have yielded promising results, indicating this technology's potential to revolutionize medical treatment. While not yet approved for human patient use, the researchers at ETH Zurich are optimistic about its future application in stroke treatment. They continue to focus on research and development, with high hopes for the robot's ability to improve the quality of life for stroke patients.

Related Links:
ETH Zurich


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Anesthetic Gas Measurement Module
Scio Four
New
Captivator EMR Device
Captivator Endoscopic Mucosal Resection Device
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: the deep tissue in vivo sound printing (DISP) platform, which combines ultrasound with low-temperature–sensitive liposomes loaded with crosslinking agents (Photo courtesy of Elham Davoodi and Wei Gao/Caltech)

New Ultrasound-Guided 3D Printing Technique to Help Fabricate Medical Implants

3D bioprinting technologies hold considerable promise for advancing modern medicine by enabling the production of customized implants, intricate medical devices, and engineered tissues designed to meet... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.